AP02 clinical trials

AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF

This study is testing a new way to give nintedanib medicine for lung scarring (IPF). It sees if a breathed-in solution (AP02) can improve lung function and is safe. Some people will get the medicine, others a dummy treatment.